Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKayaoglu, Basak
dc.contributor.authorKasap, Nurhan
dc.contributor.authorYilmaz, Naz Surucu
dc.contributor.authorCharbonnier, Louis Marie
dc.contributor.authorGeckin, Busranur
dc.contributor.authorAkcay, Arzu
dc.contributor.authorEltan, Sevgi Bilgic
dc.contributor.authorOzturk, Gulyuz
dc.contributor.authorOzen, Ahmet
dc.contributor.authorKarakoc\\-Aydiner, Elif
dc.contributor.authorChatila, Talal A.
dc.contributor.authorGursel, Mayda
dc.contributor.authorBaris, Safa
dc.date.accessioned2025-10-16T15:19:54Z
dc.date.issued2021
dc.identifier.doi10.1007/s10875-020-00943-y
dc.identifier.otherWOS:000609330000001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7428
dc.publisherSPRINGER/PLENUM PUBLISHERS
dc.sourceJOURNAL OF CLINICAL IMMUNOLOGY
dc.subjectSTAT1 gain\\-of function mutation
dc.subjectmucocutaneous candidiasis
dc.subjectautoimmunity
dc.subjectinterferon stimulated genes
dc.subjectruxolitinib
dc.subjecthematopoietic stem cell transplantation
dc.titleStepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS